ADIPOQ and breast cancer: Low-adiponectin doses mediate an anti-proliferative response in ERα-negative breast cancer cells through the regulation of genes involved in cell cycle, such as p53, Bax, Bcl-2, c-myc, and Cyclin D1 (66).